Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001178913-23-002885
Filing Date
2023-08-15
Accepted
2023-08-15 16:10:25
Documents
3
Period of Report
2023-08-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A zk2330113.htm DEF 14A 723439
2 image0.jpg GRAPHIC 2436
3 image00001.jpg GRAPHIC 6608
  Complete submission text file 0001178913-23-002885.txt   737203
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38556 | Film No.: 231174939
SIC: 2836 Biological Products, (No Diagnostic Substances)